APOA5 and metabolic syndrome: In this comparison of genotype frequencies between individuals with and without dyslipidemia (see Table 3), three of the evaluated polymorphisms (IL6_1800796, PON1_Q192R, and APOA5_rs662799) showed no statistically significant differences (p > 0.05).